65,437 trials
Prostate Cancer
Primary: Number of Participants Achieving Pathological Complete Response — 0 participants
Pain, Neuropathic · Epilepsy · Renal Pelvis Cancer
Primary: Number of All-Cancer Cases and Matched Controls With the Indicated Exposure to Gabapentin — 804; 6507; 178334; 1704443 participants — p=0.0002
Anorexia Nervosa
Primary: Change in Levels of Insulin Like Growth Factor-1 (IGF-I) Following Recombinant Human (rh) IGF-1 Administration in Girls With Anorexia Nervosa — 542.9 ng/ml — p=<0.05
Acne Vulgaris
Primary: Skin Erythema (Redness) — 1.56; 1.89; 2.62; 2.65 Units on a scale — p=>0.05
Friedreich's Ataxia
Primary: Change in ICARS — 1.1 units on a scale
Urinary Tract Infections · Urinary Tract; Accessory
Primary: Rate of Catheter-associated Urinary Tract Infection — 10; 12 infections per 1000 days
Breast Cancer With Bone Metastasis
Primary: Annual Overall Skeletal Morbidity Rate (SMR) — 0.26; 0.22 Number of Skeletal Events per Year
Diabetes Mellitus, Type 2
Primary: HbA1c Change From Baseline at Week 24 — 0.13; -0.64; -1.07; -0.45 Percent — p=<0.0001
Non-inflammatory Joint Diseases
Primary: Composite Success/Failure — 142; 141 Participants
Infections, Rotavirus · Rotavirus Vaccines
Primary: Number of Subjects Reporting Grade 2 or 3 Symptoms (Fever, Vomiting or Diarrhea). — 147; 98; 212 Subjects
HIV-1 Infections
Primary: Evolution of the HIV Viral Response — 0; 51; 0; 3 participant
Vascular Diseases
Primary: Number of Vessel Segments Visualized With Diagnostic Quality — 8.10; 8.33; 8.03; 8.33 vessel segments
Multiple Myeloma
Primary: Transplant With DT PACE-Melphalan Regimen of Chemotherapy vs. Transplant With Melphalan Alone.
HIV Infections
Primary: Percent of Participants With Treatment Failure, Defined as a Confirmed Virologic Failure or Permanent Discontinuation of the Randomized NNRTI or PI Component of Study…
Brain Metastases
Primary: Number of Lesions Detected by Blinded Readers (BR) and Investigator — 6.28; 6.92; 6.87; 6.36 lesions